Circulation: Heart Failure, 2022
Proteomic Biomarkers of Sacubitril/Valsartan Treatment Response in Heart Failure With Preserved Ejection Fraction: Molecular Insights Into Sex Differences

Nguyen T., Wang M., Liu D. et al.

Clinical and Experimental Immunology, 2022
Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response

Valli A., Kuuliala K., Virtanen A. et al.

Environmental Research, 2022
Ambient air pollution and inflammation-related proteins during early childhood

He S., Klevebro S., Baldanzi G. et al.

Diabetologia, 2022
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women

Mendham A., Micklesfield L., Karpe F. et al.

Clinical & Experimental Allergy, 2022
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma

Kere M., Klevebro S., Hernandez‐Pacheco N. et al.

Science Translational Medicine, 2022
A shift in lung macrophage composition is associated with COVID-19 severity and recovery

Chen S., Park M., Del Valle D. et al.

Journal of Critical Care, 2022
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort

Linné E., Elfström A., Åkesson A. et al.

Nature Cardiovascular Research, 2022
Age-dependent sex differences in cardiometabolic risk factors

Zhernakova D., Sinha T., Andreu-Sánchez S. et al.

ESC Heart Failure, 2022
Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Bracun V., van Essen B., Voors A. et al.

Diabetes, Obesity and Metabolism, 2022
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial

Razaghizad A., Sharma A., Ni J. et al.

Alzheimer's Research & Therapy, 2022
Association of the inflammation-related proteome with dementia development at older age: results from a large, prospective, population-based cohort study

Trares, K., Bhardwaj et al.

Clinical Kidney Journal, 2022
The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort

Schmidt I., Myrick S., Liu J. et al.

Journal of Neuroinflammation, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Pfeuffer S., Rolfes L., Wirth T. et al.

Journal of Clinical Immunology, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Borgström E., Edvinsson M., Pérez L. et al.

Journal of the American Society of Nephrology, 2022
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity

Sun Z., Zhang Z., Banu K. et al.

Neurology Neuroimmunology & Neuroinflammation, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis

Thonhoff J., Berry J., Macklin E. et al.

JACC: Heart Failure, 2022
Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

Pandhi P., ter Maaten J., Anker S. et al.

International Journal of Cancer, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Tzaridis T., Weller J., Bachurski D. et al.

European Heart Journal, 2022
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme

Zannad F., Ferreira J., Butler J. et al.

Gut, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity

Pierre N., Huynh-Thu V., Marichal T. et al.